Endometrial carcinoma · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | surveillance |
|---|---|
| Linked regimen | None |
| ID | IND-IATROGENIC-TAMOXIFEN-ENDOMETRIAL-PREVENTION-OBSERVATION |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-ENDOMETRIAL |
| Sources | SRC-NCCN-UTERINE-2025 |
Notes
STUB — alternative-track for tamoxifen endometrial-prevention. §15.2 C4 ≥2-tracks invariant.
Used By
Contraindications
CI-TAMOXIFEN-ENDOMETRIAL-HYPERPLASIA- CI-TAMOXIFEN-ENDOMETRIAL-HYPERPLASIACI-TAMOXIFEN-VTE-HISTORY- CI-TAMOXIFEN-VTE-HISTORY